App based intervention trial for anxiety and depression.

Low Cost App based Intervention Dialog Plus For Anxiety And Depression In Outpatient Psychiatric Setting Pragmatic Multisite Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092477

Enrollment

336

Registered

2025-08-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F30-F39- Mood [affective] disorders Health Condition 2: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders

Interventions

Intervention1: DIALOG+: The DIALOG scale along with a four-step solution focussed method is employed to address the patients concerns and reach a consensus on further actions. The four- step strategy

Anticipating the Future (What is the optimal outcome?) What constitutes the minimal advancement?

Evaluating Alternatives (What actions can the patient, doctor, or others undertake?)

and ultimately, Reaching Consensus on Actions (e.g.,assignments and referrals). Treatment as usual is Provided Control Intervention1: DIALOG scale: The DIALOG Scale uses a 7-point Likert scale to asse

Eligibility

Inclusion criteria

Inclusion criteria: Individuals with depression or anxiety disorders(ICD-10 F30-F39,F40-F49)excluding bipolar disorder. Currently experiencing anxiety and or depression. Receiving treatment in the out-patient services of the sites. Currently not an inpatient. Score less than or equal to 5 on MANSA. Capacity to provide informed consent. Ability to communicate in Tamil or English.

Exclusion criteria

Exclusion criteria: Major medical or Psychiatric comorbidities Current alcohol or substance use disorder (except nicotine) Pregnant or lactating mothers

Design outcomes

Primary

Measure	Time frame
Manchester Short Assessment of Quality of Life (MANSA)Timepoint: Baseline - 0 months Midline - 3 months Endline - 6 months	—

Secondary

Measure	Time frame
Depression Anxiety and Stress Scale (DASS 21). Timepoint: Baseline - 0 months Midline - 3 months Endline - 6 months;Hamiltion Anxiety Rating Scale (HAM-A)Timepoint: Baseline - 0 months Midline - 3 months Endline - 6 months;Hamilton Depression Rating Scale (HAM-D)Timepoint: Baseline - 0 months Midline - 3 months Endline - 6 months	—

Countries

India

Contacts

Public ContactDr Padmavati Ramachandran

Schizophrenia Research Foundation (India)

padmavati@scarfindia.org04426151073

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 3, 2026